Cingulate Inc.: insider trading
59 trades by 12 directors, officers and 10% owners since 2021, from their SEC Form 4 and 5 filings.
Bought, 12 months
$657 K
5 purchases by 5 insiders
Sold, 12 months
$0
0 sales by 0 insiders
Bought, 3 months
$0
0 purchases
Sold, 3 months
$0
0 sales
Insider buying and selling by month
Open-market purchases and sales by value, last three years.
Insiders (12)
Each insider's latest direct holding and their open-market trades of the last 12 months, most recent first.
| Insider | Shares owned directly | Bought, 12 m | Sold, 12 m | Latest trade |
|---|---|---|---|---|
| Jennifer L. CallahanEVP and CFO | 13,961 | $25 K | — | |
| Matthew BramsEVP and Chief Medical Officer | 8,157 | $10 K | — | |
| Nilay Dahyabhai PatelEVP, CLO and CCO | 3,389 | — | — | |
| Raul R. SilvaEVP and CSO | 4,645 | — | — | |
| Shane J. SchafferChief Executive Officer, Director | 4,076 | $34 K | — | |
| Thomas Jeffrey HargrovesDirector | 8,300 | $490 K | — | |
| Peter J. WerthDirector | — | $98 K | — | |
| Laurie MyersEVP and COO | 0 | — | — | |
| Craig S. GilgallonEVP, GC and Secretary | 9,550 | — | — | |
| Gregg Wm GivensDirector | 154,318 | — | — | |
| Curtis MedeirosDirector | 0 | — | — | |
| Louis G. Van HornEVP and CFO | 15,000 | — | — |